Study of cerebrospinal fluid flow dynamics in TGF-β1 induced chronic hydrocephalic mice

Neurological Research

Volumn 22, Issue 2, 2000, Pages 215-222

  Moinuddin, Syed M ^a   Tada, Tsuyoshi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebrospinal fluid; Communicating hydrocephalus; Leptomeninx; Mice; TGF 1

Indexed keywords

RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ARTICLE; BRAIN HEMORRHAGE; CEREBROSPINAL FLUID; CHRONIC DISEASE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXPERIMENTAL MODEL; HYDROCEPHALUS; LEPTOMENINX; MOUSE; NONHUMAN; SUBARACHNOID HEMORRHAGE;

EID: 0034079684     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.2000.11741064     Document Type: Article

References (41)

1. Hochwald GM. Mini review. Animal models of hydrocephalus: Recent developments. Proc Soc Exp Biol Med 1985; 178: 1-11
2. Ingraham FD, Alexander E, Matson DD. Experimental hydrocephalus. J Neurosurg 1947; 4: 164-1 76
3. Milhorat TH. Experimental hydrocephalus. Part 1 : A technique for producing obstructive hydrocephalus in the monkey. J Neurosurg 1970; 32: 385-389
4. Page LK, White WP. Transsphenoidal injection of silicone for the production of communicating or obstructive hydrocephalus in dogs. Surg Neurol 1982; 17: 247-250
5. Wisniewski H, Weller RO, Terry RD. Experimental hydrocephalus produced by the subarachnoid infusion of silicone oil. J Neurosurg 1969; 31: 10-14
6. James AE, Flor WJ, Bush M, Merz T, Rish BL. An experimental model for chronic communicating hydrocephalus. J Neurosurg 1974; 41: 32-37
7. Schurr PH, McLaurin RL, Ingraham FD. Experimental studies on the circulation of the cerebrospinal fluid and methods of producing communicating hydrocephalus in dogs. J Neurosurg 1953; 10: 515-525
8. Kanno T, Nakamura T, Jain VK, Sugimoto T. An experimental model of communicating hydrocephalus in C57 black mouse. Acta Neurchir (Wien) 1987; 86: 111 -114
9. Kitazawa K, Tada T. Elevation of transforming growth factor-β1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke 1994; 25: 1400-1404
10. Kanaji M, Tada T, Kobayashi S. A murine model of communicating hydrocephalus: Role of TGF-β1. J Clin Neurosci 1997; 4: 51-56
11. Tada T, Kanaji M, Kobayashi S. Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-β1. J Neuroimmunol 1994; 50: 153-158
12. Black PM. Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms. Neurosurgery 1986; 18: 12-16
13. Graff-Radford NR, Torner J, Adams HP Jr, Kassell NF. Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Arch Neurol 1989; 46: 744-752
14. Kolluri VRS, Sengupta RP. Symptomatic hydrocephalus following aneurysmal subarachnoid hemorrhage. Surg Neurol 1984; 21: 402-404
15. Vassilouthis J, Richardson AE. Ventricular dilatation and communicating hydrocephalus following spontaneous subarachnoid hemorrhage. J Neurosurg 1979; 51: 341-351
16. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with 'normal' cerebrospinalfluid pressure. New Engl J Med 1965; 273: 117-126
17. Börgesen SE, Gjerris F. The predictive value of conductance to outflow of CSF in normal pressure hydrocephalus. Brain 1982; 105: 65-86
18. Wier B. Intracranial aneurysms and subarachnoid hemorrhage: An overview. In: Wilkins RH, Rengachary SS, eds. Neurosurgery, Vol 2, New York: McGraw-Hill, 1985: pp. 1308-1329
19. Ostertag CB, Mundinger F. Diagnosis of normal-pressure hydrocephalus using CT with CSF enhancement. Neuroradiology 1978; 16: 216-219
20. Wikkelso C, Andersson H, Blomstrand C, Matousek M, Svendsen P. Computed tomography of the brain in the diagnosis of and prognosis in normal pressure hydrocephalus. Neuroradiology 1989; 31: 160-165
21. Derynck R, Jarrett JA, Chen EY, Goeddel DV. The murine transforming growth factor-β precursor. J Biol Chem 1986; 261: 4377-4379
22. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-β in human platelets. Identification of major storage site, purification, and characterization. J Biol Chem 1983; 258: 7155-7160
23. Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 1987; 105: 965-975
24. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. Transforming growth factor type-β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83: 4167-4171
25. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-β: Biological function and chemical structure. Science 1986; 233: 532-534
26. Ignotz RA, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-4345
27. Annoni G, Weiner FR, Zern MA. Increased transforming growth factor-β1 gene expression in human liver disease. J Hepatol 1992; 14: 259-264
28. Border WA, Noble NA. Cytokines in kidney disease: The role of transforming growth factor-β. Am J Kidney Dis 1993; 22: 105-113
29. Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and c in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991; 324: 933-940
30. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am J Resp Cell Mol Biol 1991; 5: 155-162
31. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J Exp Med 1987; 165: 251-256
32. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987; 84: 5788-5792
33. Oda Y, Nakanishi I. Ultrastructure of the mouse leptomeninx. J Comp Neurol 1984; 225: 448-457
34. Kida S, Pantazis A, Weller RO. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol Appl Neurobiol 1993; 19: 480-488
35. Nitta J, Tada T. Ultramicroscopic structures of meninges of mice with communicating hydrocephalus induced by human recombinant transforming growth factor-β1. Neurol Med Chir (Tokyo) 1998; 38: 819-825
36. Akai K, Uchigasaki S, Tanaka U, Komatsu A. Normal pressure hydrocephalus, neuropathological study. Acta Pathol Jpn 1987; 37: 97-110
37. DeLand FH, James AE, Ladd DJ, Konigsmark BW. Normal pressure hydrocephalus: A histologic study. Am J Clin Path 1972; 58: 58-63
38. Kibler RF, Couch RSC, Crompton MR. Hydrocephalus in the adult following spontaneous subarachnoid hemorrhage. Brain 1961; 84: 45-61
39. Motohashi O, Suzuki M, Shida N, Umezawa K, Ohtoh T, Sakurai Y, Yoshimoto T. Subarachnoid haemorrhage induced proliferation of leptomeningeal cells and deposition of extracellular matrices in the arachnoid granulations and subarachnoid space. Immunohistochemical study. Acta Neurochir (Wien) 1995; 136: 88-91
40. Shulman K, Martin BF, Popoff N, Ransohoff J. Recognition and treatment of hydrocephalus following spontaneous subarachnoid hemorrhage. J Neurosurg 1963; 20: 1040-1049
41. Boon AJW, Tan JTJ, Delwel EJ, Egeler-Peerdeman SM, Hanlo PW, Wurzer HAL, Avezaat CJJ, Jong DA, Gooskens RHJM, Hermans J. Dutch normal-pressure hydrocephalus study: Prediction of out-come after shunting by resistance to outflow of cerebrospinal fluid. J Neurosurg 1997; 87: 687-693